Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Lorch

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
European Urology|November 13, 2022
Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST)Andreas Hiester, Yue Che, Achim Lusch, et al.
Oncology Research and Treatment|August 13, 2023
No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural AreasDennis Hoch, Simon Helnwein, Davide Adrizzone, et al.
Onkologie|February 25, 2011
Interdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patientsRichard Cathomas, Michael Hartmann, Susanne Krege, et al.
Oncology|March 11, 2010
Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumorKarin Oechsle, Anja Lorch, Friedemann Honecker, et al.
World Journal of Urology|October 31, 2020
Short-term and long-term outcomes after resection of thoracic growing teratoma syndromeStefan Sponholz, Kyriaki Chalepaki Ntelli, Georgios Karaindros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trialAnja Lorch, Antje Kleinhans, Andrew Kramar, et al.
BMC Cancer|September 15, 2023
Excellent survival in relapsed stage I testicular cancerPhilip Speicher, Christian D Fankhauser, Anja Lorch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 25, 2011
Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patientsRainer Souchon, Michael Hartmann, Susanne Krege, et al.
Swiss Medical Weekly|April 20, 2023
Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart reviewMarco Notarfrancesco, Christian D Fankhauser, Anja Lorch, et al.
Journal of Cancer Research and Clinical Oncology|September 21, 2018
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study GroupMartin Fenner, Christoph Oing, Annette Dieing, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
European Urology|November 13, 2022
Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST)Andreas Hiester, Yue Che, Achim Lusch, et al.
Oncology Research and Treatment|August 13, 2023
No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural AreasDennis Hoch, Simon Helnwein, Davide Adrizzone, et al.
Onkologie|February 25, 2011
Interdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patientsRichard Cathomas, Michael Hartmann, Susanne Krege, et al.
Oncology|March 11, 2010
Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumorKarin Oechsle, Anja Lorch, Friedemann Honecker, et al.
World Journal of Urology|October 31, 2020
Short-term and long-term outcomes after resection of thoracic growing teratoma syndromeStefan Sponholz, Kyriaki Chalepaki Ntelli, Georgios Karaindros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trialAnja Lorch, Antje Kleinhans, Andrew Kramar, et al.
BMC Cancer|September 15, 2023
Excellent survival in relapsed stage I testicular cancerPhilip Speicher, Christian D Fankhauser, Anja Lorch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 25, 2011
Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patientsRainer Souchon, Michael Hartmann, Susanne Krege, et al.
Swiss Medical Weekly|April 20, 2023
Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart reviewMarco Notarfrancesco, Christian D Fankhauser, Anja Lorch, et al.
Journal of Cancer Research and Clinical Oncology|September 21, 2018
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study GroupMartin Fenner, Christoph Oing, Annette Dieing, et al.
Pageof 8